Newsroom

Delivering the latest news
from LOTTE BIOLOGICS

Key visual

SNS January 23, 2026

🏭 Facility Friday | Syracuse Bio Campus Overview

 

🏭 Facility Friday | Syracuse Bio Campus Overview

What makes a manufacturing site truly client centric?

Our Syracuse Bio Campus was previously an internal commercial manufacturing plant for a leading global biopharma. Many of our team members have stood where our clients stand today.
So we understand your priorities, concerns, and expectations, while knowing when to be flexible.

🧬 Integrated capabilities at Syracuse
Phase-appropriate drug substance manufacturing for mammalian-cell-based biologics
Fully integrated ADC manufacturing supported by onsite conjugation facilities
Operations guided by SMEs with real drug-development experience

🧪 8x 5,000 L Stainless Steel bioreactors
Large 5,000 L stainless-steel bioreactors are especially advantageous for multiple scale products and provides meaningful advantages for programs that need both scale and execution flexibility.

🛡️Regulatory excellence: 
A long-standing track record supporting more than 62 regulatory approvals across global markets
Zero critical observations across regulatory inspections to date

📍Join us each week as Facility Fridays highlights our sites, technologies, and the capabilities that power our work.